ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,988Medicare Part D Prescriptions Filled, Including Refills

Rank: 226 out of 5176

$682K Total Retail Price of All Prescriptions

Rank: 658 out of 5176

574 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 13,570 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 1,199 1,101 1 2
SIMVASTATIN 896 790 2 1
HYDROCHLOROTHIAZIDE 814 721 3 10
METFORMIN HCL 686 593 4 7
METOPROLOL TARTRATE 585 523 5 6
CRESTOR 530 509 6 15
LOSARTAN POTASSIUM 477 438 7 14
RAMIPRIL 422 358 8 50
FAMOTIDINE 398 347 9 58
OMEPRAZOLE 388 360 10 3
LISINOPRIL 353 316 11 5
ALENDRONATE SODIUM 349 349 12 18
ATENOLOL 328 285 13 12
GLIPIZIDE 268 231 14 63
NEXIUM 243 196 15 16
FUROSEMIDE 233 220 16 8
GABAPENTIN 216 185 17 21
JANUVIA 216 201 17 25
FOSINOPRIL SODIUM 211 195 19 105
LEVOTHYROXINE SODIUM 210 209 20 4
FLUTICASONE PROPIONATE 195 182 21 38
TAMSULOSIN HCL 179 170 22 20
ALCOHOL SWABS 158 145 23 115
CLOPIDOGREL 155 140 24 26
PRAVASTATIN SODIUM 151 146 25 23
PLAVIX 142 135 26 29
PRANDIN 140 134 27 150
GLYBURIDE 137 113 R 28 67
HYDRALAZINE HCL 136 117 29 73
PROAIR HFA 127 103 30 60
ACTOS 126 124 31 85
CARVEDILOL 123 110 32 24
ADVAIR DISKUS 118 107 33 32
TRAMADOL HCL 116 111 34 40
VENTOLIN HFA 112 106 35 64
LANTUS 103 95 36 66
LANTUS SOLOSTAR 99 89 37 70
DIOVAN 90 90 38 19
ATORVASTATIN CALCIUM 89 76 39 9
ZOLPIDEM TARTRATE 81 73 40 17
DOXAZOSIN MESYLATE 81 81 40 103
SERTRALINE HCL 77 64 42 30
SINGULAIR 75 72 43 62
ISOSORBIDE DINITRATE 68 63 44 288
METOPROLOL SUCCINATE 68 68 44 11
WARFARIN SODIUM 67 65 46 13
ALCOHOL PREP PADS 66 57 47 198
SPIRIVA 64 62 48 54
INSULIN SYRINGE 64 54 48 137
PEN NEEDLE 63 61 50 144
CLONIDINE HCL 62 49 51 79
PROVENTIL HFA 61 60 52 226
OXYBUTYNIN CHLORIDE 60 58 53 227
ZETIA 53 48 54 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.